Hypertension and decreased aortic compliance due to reduced elastin amounts do not increase atherosclerotic plaque accumulation in Ldlr-/- mice

Atherosclerosis

Volumn 249, Issue , 2016, Pages 22-29

  Maedeker, Justine A ^a   Stoka, Kellie V ^a   Bhayani, Siddharth A ^b   Gardner, William S ^b   Bennett, Lisa ^b   Procknow, Jesse D ^a   Staiculescu, Marius C ^a   Walji, Tezin A ^c   Craft, Clarissa S ^c   Wagenseil, Jessica E ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b Saint Louis University   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial compliance; Arterial stiffness; Atherosclerosis; Elastin; Hypertension

Indexed keywords

CHOLESTEROL; COLLAGEN; CXCL1 CHEMOKINE; ELASTIN; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; CYTOKINE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ROOT; AORTIC COMPLIANCE; ARTICLE; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; FEMALE; FLUORESCENCE; GENOTYPE; HYPERTENSION; IMMUNOASSAY; LOW DENSITY LIPOPROTEIN RECEPTOR KO MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLAQUE ACCUMULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WESTERN DIET; ANIMAL; AORTIC DISEASE; ATHEROSCLEROSIS; BLOOD; COMPLICATION; DISEASE MODEL; GENETICS; HETEROZYGOTE; KNOCKOUT MOUSE; MECHANICAL STRESS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL; CYTOKINES; DISEASE MODELS, ANIMAL; ELASTIN; FEMALE; GENOTYPE; HETEROZYGOTE; HYPERTENSION; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; STRESS, MECHANICAL;

EID: 84962381522     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.03.022     Document Type: Article

References (55)

1. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
2. Santos-Gallego C.G., Picatoste B., Badimon J.J. Pathophysiology of acute coronary syndrome. Curr. Atheroscler. Rep. 2014, 16:401.
3. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E., Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The bogalusa heart study. N. Engl. J. Med. 1998, 338:1650-1656.
4. McGill H.C., McMahan C.A., Zieske A.W., Malcom G.T., Tracy R.E., Strong J.P. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 2001, 103:1546-1550.
5. Irace C., Cortese C., Fiaschi E., Carallo C., Sesti G., Farinaro E., Gnasso A. Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. Hypertension 2005, 45:597-601.
6. Oyama N., Gona P., Salton C.J., Chuang M.L., Jhaveri R.R., Blease S.J., Manning A.R., Lahiri M., Botnar R.M., Levy D., Larson M.G., O'Donnell C.J., Manning W.J. Differential impact of age, sex, and hypertension on aortic atherosclerosis: the framingham heart study. Arterioscler. Thromb. Vasc. Biol. 2008, 28:155-159.
7. van Popele N.M., Grobbee D.E., Bots M.L., Asmar R., Topouchian J., Reneman R.S., Hoeks A.P., van der Kuip D.A., Hofman A., Witteman J.C. Association between arterial stiffness and atherosclerosis: the rotterdam study. Stroke A J. Cereb. Circ. 2001, 32:454-460.
8. Selwaness M., van den Bouwhuijsen Q., Mattace-Raso F.U., Verwoert G.C., Hofman A., Franco O.H., Witteman J.C., van der Lugt A., Vernooij M.W., Wentzel J.J. Arterial stiffness is associated with carotid intraplaque hemorrhage in the general population: the rotterdam study. Arterioscler. Thromb. Vasc. Biol. 2014, 34:927-932.
9. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein e-deficient mice created by homologous recombination in es cells. Cell 1992, 71:343-353.
10. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein e. Science 1992, 258:468-471.
11. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
12. Whitman S.C. A practical approach to using mice in atherosclerosis research. Clin. Biochem. Rev. 2004, 25:81-93.
13. Van Herck J.L., De Meyer G.R., Martinet W., Van Hove C.E., Foubert K., Theunis M.H., Apers S., Bult H., Vrints C.J., Herman A.G. Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein e-deficient mice. Circulation 2009, 120:2478-2487.
14. Robinson P.N., Arteaga-Solis E., Baldock C., Collod-Beroud G., Booms P., De Paepe A., Dietz H.C., Guo G., Handford P.A., Judge D.P., Kielty C.M., Loeys B., Milewicz D.M., Ney A., Ramirez F., Reinhardt D.P., Tiedemann K., Whiteman P., Godfrey M. The molecular genetics of marfan syndrome and related disorders. J. Med. Genet. 2006, 43:769-787.
15. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., Myers L., Klein E.C., Liu G., Calvi C., Podowski M., Neptune E.R., Halushka M.K., Bedja D., Gabrielson K., Rifkin D.B., Carta L., Ramirez F., Huso D.L., Dietz H.C. Losartan, an at1 antagonist, prevents aortic aneurysm in a mouse model of marfan syndrome. Science 2006, 312:117-121.
16. Ramirez F., Sakai L.Y., Dietz H.C., Rifkin D.B. Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology. Physiol. Genomics. 2004, 19:151-154.
17. Judge D.P., Biery N.J., Keene D.R., Geubtner J., Myers L., Huso D.L., Sakai L.Y., Dietz H.C. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of marfan syndrome. J. Clin. Invest. 2004, 114:172-181.
18. Gayral S., Garnotel R., Castaing-Berthou A., Blaise S., Fougerat A., Berge E., Montheil A., Malet N., Wymann M.P., Maurice P., Debelle L., Martiny L., Martinez L.O., Pshezhetsky A.V., Duca L., Laffargue M. Elastin-derived peptides potentiate atherosclerosis through the immune neu1-pi3kgamma pathway. Cardiovasc Res. 2014, 102:118-127.
19. Faury G., Pezet M., Knutsen R.H., Boyle W.A., Heximer S.P., McLean S.E., Minkes R.K., Blumer K.J., Kovacs A., Kelly D.P., Li D.Y., Starcher B., Mecham R.P. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J. Clin. Invest. 2003, 112:1419-1428.
20. Milewicz D.M., Urbán Z., Boyd C.D. Genetic disorders of the elastic fiber system. Matrix Biol. 2000, 19:471-480.
21. Li D.Y., Faury G., Taylor D.G., Davis E.C., Boyle W.A., Mecham R.P., Stenzel P., Boak B., Keating M.T. Novel arterial pathology in mice and humans hemizygous for elastin. J. Clin. Invest. 1998, 102:1783-1787.
22. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., Eichwald E., Keating M.T. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393:276-280.
23. Wagenseil J.E., Nerurkar N.L., Knutsen R.H., Okamoto R.J., Li D.Y., Mecham R.P. Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1209-H1217.
24. Tangirala R.K., Rubin E.M., Palinski W. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in ldl receptor-deficient and apolipoprotein e-deficient mice. J. Lipid Res. 1995, 36:2320-2328.
25. Semenkovich C.F., Coleman T., Daugherty A. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J. Lipid Res. 1998, 39:1141-1151.
26. Shen Z., Lu Z., Chhatbar P.Y., O'Herron P., Kara P. An artery-specific fluorescent dye for studying neurovascular coupling. Nat. Methods 2012, 9:273-276.
27. Clifford P.S., Ella S.R., Stupica A.J., Nourian Z., Li M., Martinez-Lemus L.A., Dora K.A., Yang Y., Davis M.J., Pohl U., Meininger G.A., Hill M.A. Spatial distribution and mechanical function of elastin in resistance arteries: a role in bearing longitudinal stress. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2889-2896.
28. Krahn K.N., Bouten C.V., van Tuijl S., van Zandvoort M.A., Merkx M. Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal. Biochem. 2006, 350:177-185.
29. Merat S., Casanada F., Sutphin M., Palinski W., Reaven P.D. Western-type diets induce insulin resistance and hyperinsulinemia in ldl receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1223-1230.
30. Coenen K.R., Gruen M.L., Chait A., Hasty A.H. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 2007, 56:564-573.
31. Hartvigsen K., Binder C.J., Hansen L.F., Rafia A., Juliano J., Horkko S., Steinberg D., Palinski W., Witztum J.L., Li A.C. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2007, 27:878-885.
32. Ma Y., Wang W., Zhang J., Lu Y., Wu W., Yan H., Wang Y. Hyperlipidemia and atherosclerotic lesion development in ldlr-deficient mice on a long-term high-fat diet. PLoS One 2012, 7:e35835.
33. Gupte M., Boustany-Kari C.M., Bharadwaj K., Police S., Thatcher S., Gong M.C., English V.L., Cassis L.A. Ace2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R781-R788.
34. Symons J.D., McMillin S.L., Riehle C., Tanner J., Palionyte M., Hillas E., Jones D., Cooksey R.C., Birnbaum M.J., McClain D.A., Zhang Q.J., Gale D., Wilson L.J., Abel E.D. Contribution of insulin and akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 2009, 104:1085-1094.
35. Wagenseil J.E., Knutsen R.H., Li D.Y., Mecham R.P. Elastin-insufficient mice show normal cardiovascular remodeling in 2k1c hypertension despite higher baseline pressure and unique cardiovascular architecture. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H574-H582.
36. Lee H.Y., Oh B.H. Aging and arterial stiffness. Circ. J. Official J. Jpn. Circ. Soc. 2010, 74:2257-2262.
37. Lu H., Cassis L.A., Daugherty A. Atherosclerosis and arterial blood pressure in mice. Curr. Drug Targets 2007, 8:1181-1189.
38. van Thiel B.S., van der Pluijm I., Te Riet L., Essers J., Danser A.H. The renin-angiotensin system and its involvement in vascular disease. Eur. J. Pharmacol. 2015, 763(Pt A):3-14.
39. Tham D.M., Martin-McNulty B., Wang Y.X., Da Cunha V., Wilson D.W., Athanassious C.N., Powers A.F., Sullivan M.E., Rutledge J.C. Angiotensin ii injures the arterial wall causing increased aortic stiffening in apolipoprotein e-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R1442-R1449.
40. Doran D.E., Weiss D., Zhang Y., Griendling K.K., Taylor W.R. Differential effects of at1 receptor and ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species. Atherosclerosis 2007, 195:39-47.
41. Wassmann S., Czech T., van Eickels M., Fleming I., Bohm M., Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein e/angiotensin ii type 1a receptor double-knockout mice. Circulation 2004, 110:3062-3067.
42. Weiss D., Kools J.J., Taylor W.R. Angiotensin ii-induced hypertension accelerates the development of atherosclerosis in apoe-deficient mice. Circulation 2001, 103:448-454.
43. Weng S., Sprague J.E., Oh J., Riek A.E., Chin K., Garcia M., Bernal-Mizrachi C. Vitamin d deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 2013, 8:e54625.
44. Tikellis C., Pickering R.J., Tsorotes D., Huet O., Chin-Dusting J., Cooper M.E., Thomas M.C. Activation of the renin-angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein e knockout mouse. Hypertension 2012, 60:98-105.
45. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
46. Henson G.D., Walker A.E., Reihl K.D., Donato A.J., Lesniewski L.A. Dichotomous mechanisms of aortic stiffening in high-fat diet fed young and old b6d2f1 mice. Physiol. Rep. 2014, 2:e00268.
47. Lesniewski L.A., Zigler M.L., Durrant J.R., Nowlan M.J., Folian B.J., Donato A.J., Seals D.R. Aging compounds western diet-associated large artery endothelial dysfunction in mice: prevention by voluntary aerobic exercise. Exp. Gerontol. 2013, 48:1218-1225.
48. Du B., Ouyang A., Eng J.S., Fleenor B.S. Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2015, 308(11):H1382-H1390. ajpheart 00712 02014.
49. Grainger D.J. Tgf-beta and atherosclerosis in man. Cardiovasc Res. 2007, 74:213-222.
50. Redondo S., Santos-Gallego C.G., Tejerina T. Tgf-beta1: a novel target for cardiovascular pharmacology. Cytokine Growth Factor Rev. 2007, 18:279-286.
51. Matt P., Schoenhoff F., Habashi J., Holm T., Van Erp C., Loch D., Carlson O.D., Griswold B.F., Fu Q., De Backer J., Loeys B., Huso D.L., McDonnell N.B., Van Eyk J.E., Dietz H.C., Gen T.A.C.C. Circulating transforming growth factor-beta in marfan syndrome. Circulation 2009, 120:526-532.
52. Greenwald S.E. Ageing of the conduit arteries. J. Pathol. 2007, 211:157-172.
53. Kamenskiy A.V., Pipinos, Carson J.S., MacTaggart J.N., Baxter B.T. Age and disease-related geometric and structural remodeling of the carotid artery. J. Vasc. Surg. 2014, 62(6):1521-1528.
54. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross J., Honjo T., Chien K.R. Fibulin-5/dance is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
55. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., Olson E.N. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002, 415:168-171.